Rivus Pharmaceuticals has 6 close competitors: Atomwise, BioMason, Colossal Biosciences.
Sector, valuation and status for each competitor.
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
Atomwise
BioMason
Colossal Biosciences
Ecovativa Design
Formation BioPharmaceutical company developing oral medicines for cardiometabolic health and metabolic dysfunction-associated steatohepatitis (MASH), with lead therapy HU6 and secondary candidate RV-8451.
Rivus Pharmaceuticals competes with 6 companies here: Atomwise, BioMason, Colossal Biosciences, Ecovativa Design, Formation Bio, Halda Therapeutics.
The routes section explains what is realistically available for a company at this stage.
No. Rivus Pharmaceuticals is a private company; its shares do not trade on a public exchange.
The closest biotechnology/pharmaceuticals peers are on the competitors page.